Purdue Pharma logo

Purdue Pharma

North America, Connecticut, United States, Stamford

Description

Purdue Pharma develops, manufactures, and markets medications and consumer health products.

Investor Profile

Purdue Pharma has made 6 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (33%)
  • Series D (17%)
  • Grant (17%)
  • Post Ipo Equity (17%)
  • Series Unknown (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Oncology
  • Biopharma
  • Health Care
  • Non Profit
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Purdue Pharma frequently co-invest with?

Elm Street Ventures
North America, Connecticut, United States, New Haven
Co-Investments: 1
Auven Therapeutics
North America, Florida, United States, Delray Beach
Co-Investments: 2
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 3
KE
North America, Connecticut, United States, North Haven
Co-Investments: 1
Deerfield
North America, New York, United States, New York
Co-Investments: 1
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 3
TV
North America, Texas, United States, Dallas
Co-Investments: 2
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Purdue Pharma?

Harm Reduction Therapeutics

Bethesda, Maryland, United States

Harm Reduction Therapeutics is a nonprofit pharmaceutical company advancing harm reduction therapies to promote public health.

BiotechnologyHealth CareNon Profit
GrantMar 21, 2023
Amount Raised: $9,000,000
Kolltan Pharmaceuticals

New Haven, Connecticut, United States

Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.

BiotechnologyMedicalOncologyPharmaceutical
Series DMar 19, 2014
Amount Raised: $60,000,000
Infinity Pharmaceuticals

Cambridge, Massachusetts, United States

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityJul 19, 2012
Amount Raised: $27,500,000
Kolltan Pharmaceuticals

New Haven, Connecticut, United States

Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.

BiotechnologyMedicalOncologyPharmaceutical
Series AOct 12, 2009
Amount Raised: $5,000,000
Infinity Pharmaceuticals

Cambridge, Massachusetts, United States

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

BiopharmaBiotechnologyPharmaceutical
Series UnknownNov 20, 2008
Amount Raised: $75,000,000
Kolltan Pharmaceuticals

New Haven, Connecticut, United States

Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.

BiotechnologyMedicalOncologyPharmaceutical
Series AJul 31, 2008
Amount Raised: $40,000,000